Thank you for visiting this website to learn more about OPUS (Oral S1P1 Receptor ModUlation in SLE) – a clinical study testing an investigational drug, cenerimod, for the treatment of Systemic Lupus Erythematosus (SLE*).
The decision to participate in a clinical study is a very personal one. On this website, you will find detailed information about what the OPUS study involves, which you can read at your own pace. If you think that joining the OPUS study might be the right choice for you, speak to your doctor to understand the complete details of the program and how to register to potentially join the study.
*SLE is the full name for the syndrome known as Lupus. If you are not sure about the condition, discuss with your doctor for better understanding.
Philippines 
日本語 